ACRYSTA
Live / Registered — Registered (as of 07 Apr 2026)
What this means for you
Registered since 07 Apr 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Apr 2032: the §8 declaration of use).
Record
- Serial number
- 98568282
- Registration number
- 8200722
- Mark type
- Word mark
- Filed
- 24 May 2024
- Published for opposition
- 17 Feb 2026
- Registered
- 07 Apr 2026
- Next maintenance filing
- §8 declaration of use, due by 07 Apr 2032 (grace period to 07 Oct 2032)
- Attorney of record
- G Patrick SAGE II
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of pain
Owner
- ESTEVE PHARMACEUTICALS, S.A., Barcelona, ES
- ESTEVE PHARMACEUTICALS, S.A., Barcelona, ES
- ESTEVE PHARMACEUTICALS, S.A., Barcelona, ES
Prior registrations
Prosecution history
- 12 Apr 2026 — POST PUBLICATION AMENDMENT – NOT ENTERED
- 10 Apr 2026 — ASSIGNED TO PETITION STAFF
- 07 Apr 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Apr 2026 — REGISTERED-PRINCIPAL REGISTER
- 17 Feb 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Feb 2026 — PUBLISHED FOR OPPOSITION
- 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Nov 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 12 May 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 12 May 2025 — LETTER OF SUSPENSION E-MAILED
- 12 May 2025 — SUSPENSION LETTER WRITTEN
- 03 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE